Copyright
©The Author(s) 2023.
World J Crit Care Med. Mar 9, 2023; 12(2): 71-88
Published online Mar 9, 2023. doi: 10.5492/wjccm.v12.i2.71
Published online Mar 9, 2023. doi: 10.5492/wjccm.v12.i2.71
Ref. | Study type | Population | Intervention | Outcomes |
Shum et al[98], 2013 | Prospective case series with historical controls | 6 patients with septic AKI | oXiris + CVVH | Significant reduction in SOFA scores by 37% after 48 h of therapy |
Ugurov et al[96], 2020 | Single centre case series | 15 COVID -19 patients | oXiris hemofilter | Early initiation of oXiris was associated with stable or reducing levels of IL-6,8,10 and TNFα |
Zhang et al[49], 2021 | Case series | 5 COVID-19 patients | CRRT followed by oXiris hemofilter therapy | Reduced levels of cytokines, haemodynamic stabilization and improvement of organ function was observed with oXiris. |
Rosalia et al[100], 2020 | Prospective cohort study | 44 COVID 19 cases | CVVH + oXiris | Reduction in CRP, ferritin, fibrinogen and other inflammatory mediators were observed |
- Citation: Mehta Y, Paul R, Ansari AS, Banerjee T, Gunaydin S, Nassiri AA, Pappalardo F, Premužić V, Sathe P, Singh V, Vela ER. Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements. World J Crit Care Med 2023; 12(2): 71-88
- URL: https://www.wjgnet.com/2220-3141/full/v12/i2/71.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v12.i2.71